Korean J Intern Med.  2016 Mar;31(2):237-241. 10.3904/kjim.2016.026.

Angiotensin converting enzyme inhibitors remain the first treatment of choice

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Heart Center, Gachon University Gil Medical Center, Incheon, Korea. kwangk@gilhospital.com
  • 2Gachon Cardiovascular Research Institute, Incheon, Korea.
  • 3Cardiovascular Medicine, Hokko Memorial Clinic, Sapporo, Japan.
  • 4Department of Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Abstract

No abstract available.


MeSH Terms

*Angiotensin-Converting Enzyme Inhibitors
Humans
Angiotensin-Converting Enzyme Inhibitors
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr